Glossary Flashcards
adaptive immunity
immune responses mediated by lymphocytes and their products requiring activation by innate immune mechanisms on first encounter with antigen but acting immediately on subsequent encounters
afferent lymphocytes
lymphatic vessels entering lymph nodes from tissue spaces
alveolar macrophages
macrophages in the lungs
antibodies
highly variable proteins produced by B lymphocytes of the immune system and that recognise antigen and target it for destruction
Antibody-dependent cellular cytotoxicity (ADCG):
a process whereby FcR-bearing celts encounter an antibody-coated target cell and degranulate, releasing contents that kill the antibody-coated cell.
antigen
any molecule or part of a molecule recognised by the variable antigen receptors of the lymphocytes
antigenic drift
(of influenza virus) point mutations, predominantly in hemagglutinin and neuraminidase, that affect recognition by neutralizing human antibodies. Antigenic drift gives rise to epidemic infections.
shift
(of influenza virus) reassortment of independent RNA segments from two different influenza genomes to generate recombinant virus with new antigenic subtypes. Antigenic shift gives rise to pandemic outbreaks.
antigenic variation
(in parasites) clonal expression of members of proteins among parasite progeny; examples include the major surface glycoproteins of trypanosomes and the red cell adhesins encoded by malaria parasites; variant expression allows parasites to evade immune recognition
antigen presentation
the binding of fragments of intracellular molecules, usually peptides derived from proteins of pathogens, by MHC molecules and their presentation the cell surface for recognition by T cells
APC
cells capable of displaying antigen for recognition by T-celts and of activating naive T cells
Antimicrobial peptides:
peptide antibodies that provide defense against microbes and viruses by interacting with membranes of infectious agents and increasing their permeability. Human antimicrobial peptides are members of either the u-defensin, $defensin or cathelicidin families
Attenuation
(of a pathogen) loss of pathogenicity, usually through adaptation to growth in culture in adverse conditions or in cells irom a species other than that of the normal host. Attenuated pathogens are the basis of many vaccines
avidity
increased apparent affinity of a molecule for its ligand due to the presence of multiple binding sites on both partners
basophils
circulating myeloid lineage cells that-are characterised by cytoplasmic granules that stain with basic dyes and contain inflammatory mediators and are believed to be important in defence against parasites as well as in inflammatory and allergic reactions
C1q
complement component that binds to antibodies in immune complexes and activates the classical pathway of complement activation. ln addition to activating the complement cascade, Clq is recognised by a phagocytic receptor of macrophages (C1qRp), and so can mediate phagocytosis directly
C3 convertase
either of two proteolytic enzymes of the complement system that cleave the C3 to generate C3a and C3b. The C3 convertase of the classical and lectin pathways is a complex of C4b and C2b, whereas the C3 convertase of the alternative pathway is a complex of C3b and Bb
Capsular polysaccharide:
cell-surface polymers of repeating oligosaccharide units, usually linked through phosphodiester bonds, that form a capsule on the surface of many pathogenic bacteria and protect bacterial cells from recognition by phagocytes. For this reason the presence of a capsule is often associated with virulence
Cathelicidins
family of cationic antimicrobial peptides generated in pre-pro forms that require processing to generate the active peptide; cathelicidins contain an amino-terminal cathelin-like domain and a carboxy- terminal antimicrobial domain
chemokine
any of a family of closely related small, basic cytokines whose main function is as chemoaftractants. The name is a contraction of chemotactic cytokine